The annual societal cost of Parkinson's disease across Europe reached €22.8 billion in 2019, equivalent to €28.8 billion at 2025 prices, according to a new study published in Movement Disorders. As the number of people living with Parkinson's disease continues to grow, researchers warn that health and social care systems are likely to face increasing pressure.
Economic Impact of Parkinson's Disease in Europe and Its Implications
A study published in Movement Disorders reveals that the societal cost of Parkinson's disease in Europe reached €22.8 billion in 2019, projected to rise due to increasing cases. This situation highlights the strain on health systems, which could have implications for countries like Iran facing similar health challenges.
👥 Key Players
📰 What Happened
A study published in Movement Disorders highlights that the societal cost of Parkinson's disease in Europe was €22.8 billion in 2019 and is expected to rise. This increase is attributed to the growing number of individuals diagnosed with the disease.
- The cost is projected to reach €28.8 billion by 2025.
- The rising prevalence of Parkinson's disease will strain health and social care systems.
💡 Why It Matters
📚 Background
Parkinson's disease is a progressive neurological disorder that affects movement and can lead to significant healthcare costs. Understanding its economic impact is crucial for effective health policy.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%